| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| gsk3 inhibitor clinical trial | 0.7 | 0.5 | 6288 | 10 | 29 |
| gsk3 | 1.72 | 1 | 6484 | 78 | 4 |
| inhibitor | 1.98 | 0.8 | 6382 | 36 | 9 |
| clinical | 1.43 | 1 | 1416 | 32 | 8 |
| trial | 1.65 | 0.6 | 3610 | 65 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| gsk3 inhibitor clinical trial | 0.44 | 0.4 | 641 | 54 |
| gsk-3 inhibitor | 1.89 | 0.3 | 7548 | 26 |
| gsk-3 inhibitor 3 | 0.96 | 0.1 | 4831 | 33 |
| gsk-3 inhibitor bio | 0.19 | 0.9 | 3389 | 54 |
| gsk 3 beta inhibitor | 1.83 | 0.6 | 85 | 27 |
| gsk-3-inhibitor-ii | 1.08 | 0.8 | 9294 | 60 |
| gsk 3 inhibitor ix | 0.44 | 0.8 | 1019 | 31 |
| gsk clinical trial register | 0.52 | 0.7 | 5582 | 36 |
| gsk clinical trials uk | 0.28 | 0.4 | 7018 | 21 |
| rsk inhibitor clinical trial | 1.82 | 0.4 | 2213 | 70 |
| skp2 inhibitor clinical trial | 1.77 | 0.2 | 2841 | 43 |
| gsk oncology clinical trials | 0.92 | 0.9 | 3664 | 58 |
| sgk1 inhibitor in clinical trial | 0.68 | 0.8 | 2849 | 98 |
| how to inhibit gsk3b | 1.89 | 0.3 | 6899 | 86 |
| gsk3-in-3 | 0.66 | 0.3 | 4375 | 39 |
| gsk clinical trials cambridge | 0.34 | 0.1 | 9392 | 22 |
| what does gsk3 do | 1.81 | 0.8 | 6321 | 38 |
| gsk3-like kinase | 1.39 | 0.2 | 1150 | 99 |
| gsk3-beta | 1.03 | 0.6 | 9856 | 51 |
| anti-gsk3 beta therapeutic potential | 0.58 | 0.5 | 1593 | 84 |
| anti-gsk3 beta role in cancer | 0.88 | 0.4 | 2601 | 43 |
